PHILIPPINES RADIOTHERAPY MARKET ANALYSIS

Philippines Radiotherapy MarketSize and Trends

Philippines radiotherapy market is expected to reach US$ 33 Mn by 2030, from US$ 22.4 Mn in 2023, at a CAGR of 5.7% during the forecast period.

The growing prevalence of cancer in this country is anticipated to support the market development over the forecast period. For instance, the 2020 Globocan report stated that there were 153,751 new cancer cases in Philippines in 2020. Out of which, breast cancer accounted for 17.7% of the total cancer cases.

Philippines Radiotherapy Market- Trends

• Integration of artificial intelligence: The growing integration of artificial intelligence applications is having a profound impact on the radiotherapy market in the Philippines. By using advanced algorithms and machine learning techniques, AI systems are helping to optimize radiotherapy treatment planning and delivery. This allows doctors and medical physicists to more accurately target radiation doses to tumors while minimizing exposure of surrounding healthy tissues. AI is improving outcomes for patients by enabling more personalized, tailored treatment plans based on individual patients' scans, medical histories, and other key factors.
• Advanced Radiation Therapy Techniques: The use of advanced radiation therapy techniques is having a strong influence on the radiotherapy market in the Philippines. Some of the newer technologies, such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic radiosurgery are allowing doctors to better target tumors and protect healthy tissues. According to a report published by Elsevier on August 15, 2023, in 2022, there were 61 megavoltage (MV) units distributed in 51 radiation therapy (RT) facilities around the country (56 linear accelerators, Co-60 teletherapy units, and 1 gamma knife radiosurgery unit). Since 2015, when there were only 22 RT facilities, the number has more than doubled. Thirty-seven facilities (73%) are IMRT-capable, but only 12 (24%) and 9 (18%) centers conduct stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT), respectively.

Philippines Radiotherapy Market- Drivers

• Rising prevalence of cancer: The rising prevalence of cancer is the major factor driving growth of the Philippines radiotherapy Market. According to the Globocan 2020 report, 92,606 individuals succumbed to cancer in 2020, out of which 17,063 death occurred due to lung cancer, a staggering 18.4% of total cancer deaths. Additionally, the number of lung cancer cases reported in 2020 was also high, 13,406 a 19.9% of total cases reported in males.
• Increase in Healthcare expenditure: Increase in healthcare expenditure for cancer treatment has resulted in development of the radiotherapy treatment in Philippines. For instance, in March 2022, Philippine Institute for Development Studies, Philippines leading source of policy research and advice, stated that spending for cancer reached US$ 840 million in 2022, a 140.75% increase from the US$ 350 million in 2019.
• Collaboration with international organizations: Collaboration with international health organizations has significantly contributed to advancing radiotherapy services in the Philippines. The government has partnered with organizations like the International Atomic Energy Agency (IAEA) and the World Health Organization (WHO) to modernize radiotherapy infrastructure and expand access to care. Through initiatives like the IAEA's program on cancer control in developing countries, several public hospitals have received grants and assistance to purchase new linear accelerators, MR-SIM, and brachytherapy equipment since 2020.